Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 55

  1. Cat.No. Product Name Information/Activity
  2. BCC6986 CGS 19755 110347-85-8 CGS 19755 chemical structure
  3. BCC6805 (2R,3S)-Chlorpheg 140924-23-8 (2R,3S)-Chlorpheg chemical structure
  4. BCC7369 Co 101244 hydrochloride 193356-17-1 Co 101244 hydrochloride chemical structure
  5. BCC6120 Conantokin G 93438-65-4 Conantokin G chemical structure
  6. BCC5980 Conantokin-R 202925-60-8 Conantokin-R chemical structure
  7. BCC5977 Conantokin-T 127476-26-0 Conantokin-T chemical structure
  8. BCC6581 (R)-CPP 126453-07-4 (R)-CPP chemical structure
  9. BCC6561 (RS)-CPP 100828-16-8 (RS)-CPP chemical structure
  10. BCC6999 D-CPP-ene 117414-74-1 D-CPP-ene chemical structure
  11. BCC6592 5,7-Dichlorokynurenic acid 131123-76-7 5,7-Dichlorokynurenic acid chemical structure

Items 541 to 550 of 709 total